CD203c is Overexpressed on Neoplastic Mast Cells in Systemic Mastocytosis and is Upregulated upon IgE Receptor Cross-Linking
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The ectoenzyme E-NPP3 (CD203c) has recently been identified as a novel activation-linked cell surface antigen on basophils. In the present study, we examined expression of CD203c on normal mast cells (MC) and bone marrow (bm) MC derived from 85 patients with systemic mastocytosis (SM), including cases with indolent SM (ISM, n=72), SM with associated clonal hematologic non-MC-lineage disease (SM-AHNMD, n=6), aggressive SM (ASM, n=3), and mast cell leukemia (MCL, n=4). Surface expression of CD203c was analyzed by multicolor flow cytometry. In patients with SM, bm MC expressed significantly higher amounts of CD203c compared to normal bm MC (median MFI in controls: 260 versus median MFI in SM: 516, p<0.05). Slightly lower amounts of CD203c were detected on MC in SM-AHNMD and ASM compared to ISM. To demonstrate CD203c expression in MC at the mRNA level, neoplastic MC were highly enriched by cell sorting, and were found to express CD203c mRNA in RT-PCR analysis. Cross-linking of the IgE receptor on MC resulted in a substantial upregulation of CD203c, whereas the KIT-ligand stem cell factor (SCF) showed no significant effects. In conclusion, CD203c is a novel activation-linked surface antigen on MC that is upregulated in response to IgE receptor cross-linking and is overexpressed on neoplastic MC in patients with SM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reliable and established parameters of basophil- and MC activation include analysis of cell surface levels of CD63 and/or CD203c (51-55).”
From Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome (2019) · cites this paper as [55]
In the citing paper
“many of the activation-linked surface antigens, including CD63 and CD203c are upregulated on neoplastic resting MC in SM (55).”
From Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome (2019) · cites this paper as [55]
In the citing paper
“Both proteins (antigens) increase on the surface of FcεR cross-linked MC and basophils (51-55).”
From Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome (2019) · cites this paper as [55]
Citations
Cites
Diagnostic criteria and classification of mastocytosis: a consensus proposal
Valent, P., Horny, H.-P., Escribano, L., Longley, B. J., Li, C. Y., Schwartz, L. B., Marone, G., Nuñez, R., Akin, C., Sotlar, K., et al. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00038-8 · Cited by 1,108
Self-citationNagata, H., Worobec, A. S., Oh, C. K., Chowdhury, B. A., Tannenbaum, S., Suzuki, Y., & Metcalfe, D. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10560 · Cited by 872
Furitsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., Sugahara, H., Butterfield, J. H., Ashman, L. K., & Kanayama, Y. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116761 · Cited by 816
Valent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin‐Nelemans, H. C., Hamdy, N. A. T., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01807.x · Cited by 750 · cited 2×
“This is of particular interest, as severe and sometimes fatal anaphylactic reactions are seen in patients with SM, and some of these reactions may be triggered by specific IgE and then may require specific (immuno)therapy (33).”
BackgroundSelf-citationEstablishment of an immature mast cell line from a patient with mast cell leukemia
Butterfield, J. H., Weiler, D., Dewald, G., & Gleich, G. J. (1988) · Leukemia Research · doi:10.1016/0145-2126(88)90050-1 · Cited by 737
Longley, B. J., Tyrrell, L., Lu, S.-Z., Ma, Y.-S., Langley, K., Ding, T.-G., Duffy, T., Jacobs, P., Tang, L. H., & Modlin, I. (1996) · Nature Genetics · doi:10.1038/ng0396-312 · Cited by 607
Longley, B. J., Metcalfe, D. D., Tharp, M., Wang, X., Tyrrell, L., Lu, S.-Z., Heitjan, D., & Ma, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1609 · Cited by 552
Garcia-Montero, A. C. (2006) · Blood · doi:10.1182/blood-2006-04-015545 · Cited by 504
Self-citationMonitoring human basophil activation via CD63 monoclonal antibody 435
Knol, E. F., Mul, F. P. J., Jansen, H., Calafat, J., & Roos, D. (1991) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(91)90094-5 · Cited by 421 · cited 1×
“Another remarkable aspect is that several of these antigens, such as C063, also increase in expression on blood basophils or MC after crosslinking of the high affinity IgE receptor (FCERI) (19-20).”
BackgroundClassification and Diagnosis of Mastocytosis: Current Status
Metcalfe, D. D. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12468882 · Cited by 346
Research works printed but not linked: 3
- Valent P, 1996, Wien Klin Wochenschr, 108, 385
- Valent P, 2001, Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues, 1, 291
- Bühring H-J, 1999, Blood, 94, 2343
Cited by
Cellular function and molecular structure of ecto-nucleotidases
Zimmermann, H., Zebisch, M., & Sträter, N. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9309-4 · Cited by 977
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
Valent, P., Akin, C., Bonadonna, P., Hartmann, K., Brockow, K., Niedoszytko, M., Nedoszytko, B., Siebenhaar, F., Sperr, W. R., Oude Elberink, J. N. G., et al. (2019) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.01.006 · Cited by 225
“†Most of the patients suffer from CM or SM.”
BackgroundInfluentialSelf-citationValent, P., Akin, C., Hartmann, K., Nilsson, G., Reiter, A., Hermine, O., Sotlar, K., Sperr, W. R., Escribano, L., George, T. I., et al. (2020) · Theranostics · doi:10.7150/thno.46719 · Cited by 180
Self-citationMetcalfe, D. D., Pawankar, R., Ackerman, S. J., Akin, C., Clayton, F. C., Falcone, F. H., Gleich, G. J., Irani, A.-M. A., Johansson, M. W., Klion, A. D., et al. (2016) · World Allergy Organization Journal · doi:10.1186/s40413-016-0094-3 · Cited by 172
Biological implications of preformed mast cell mediators
Lundequist, A., & Pejler, G. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0587-0 · Cited by 162
Metadata
- Authors
- Hauswirth, A. W., Escribano, L., Prados, A., Nuñez, R., Mirkina, I., Kneidinger, M., Florian, S., Sonneck, K., Vales, A., Schernthaner, G.-H., Sanchez-Muñoz, L., Sperr, W. R., Bühring, H.-J., Orfao, A., & Valent, P.
- Affiliations
- Medical University of Vienna (AT)
- Hospital Universitario Ramón y Cajal (ES)
- Servicio de Hematologia, Unidad de Mastocitosis, Hospital Ramón y Cajal, Madrid, Spain
- Ludwig Boltzmann Institute for Hematology and Oncology (AT)
- University of Tübingen (DE)
- Universidad de Salamanca (ES)
- Corresponding author
- Valent, P.
- Venue
- International Journal of Immunopathology and Pharmacology
- Publisher
- SAGE Publications
- Published
- 2008-10
- Volume
- 21
- Issue
- 4
- Pages
- 797-806
- ISSN
- 0394-6320 (ISSN-L)
- 2058-7384
- OpenAlex
- W2112001648
- Cited by
- 48
- References
- 32
- Citations by year
- 2026: 1 · 2023: 1 · 2022: 5 · 2021: 1 · 2020: 1 · 2019: 5 · 2018: 3 · 2017: 2 · 2016: 5 · 2015: 1 · 2014: 4 · 2013: 3 · 2012: 4
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- International Journal of Immunopathology and Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Tumor Research and Treatment
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- CD203c, systemic mastocytosis, mast cells, mast cell leukemia, IgE receptor cross-linking, mast cell activation, stem cell factor, bone marrow mast cells, indolent systemic mastocytosis, aggressive systemic mastocytosis
- MeSH terms
- Base Sequence, Flow Cytometry, Humans, Mast Cells, Mastocytosis, Neoplasms, Phosphoric Diester Hydrolases, Pyrophosphatases, RNA, Messenger, Up-Regulation, Receptors, IgE, DNA Primers, Reverse Transcriptase Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CD203c is Overexpressed on Neoplastic Mast Cells in Systemic Mastocytosis and is Upregulated upon IgE Receptor Cross-Linking. https://app.cochat.ai/papers/10.1177/039463200802100404
- The paper
- Hauswirth, A. W., Escribano, L., Prados, A., Nuñez, R., Mirkina, I., Kneidinger, M., Florian, S., Sonneck, K., Vales, A., Schernthaner, G.-H., Sanchez-Muñoz, L., Sperr, W. R., Bühring, H.-J., Orfao, A., & Valent, P. (2008). CD203c is Overexpressed on Neoplastic Mast Cells in Systemic Mastocytosis and is Upregulated upon IgE Receptor Cross-Linking. International Journal of Immunopathology and Pharmacology. https://doi.org/10.1177/039463200802100404
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.